ATNT-03 FIRST IN HUMAN STUDY OF RHENIUM NANOLIPOSOMES FOR INTRATUMORAL THERAPY OF GLIOMA

Por Floyd, John, Phillips, William, Goins, Beth, Bao, Ande, Brenner, Andrew
Publicado no Neuro Oncol (2015)

EVIDENCE THAT INSULIN RELEASE IS THE MECHANISM FOR EXPERIMENTALLY INDUCED LEUCINE HYPOGLYCEMIA IN MAN

Por Floyd, John C., Fajans, Stefan S., Knope, Ralph F., Conn, Jerome W.
Publicado em 1963

A Comparison of Leucine- and Acetoacetate-induced Hypoglycemia in Man

Por Fajans, Stefan S., Floyd, John C., Knopf, Ralph F., Conn, Jerome W.
Publicado em 1964

THE EXPERIMENTAL INDUCTION IN MAN OF SENSITIVITY TO LEUCINE HYPOGLYCEMIA

Por Fajans, Stefan S., Knopf, Ralph F., Floyd, John C., Power, Lawrence, Conn, Jerome W.
Publicado em 1963

Clinical characteristics and treatment outcomes of patients with colorectal cancer who develop brain metastasis: a single institution experience

Por Fountzilas, Christos, Chang, Katherine, Hernandez, Brian, Michalek, Joel, Crownover, Richard, Floyd, John, Mahalingam, Devalingam
Publicado no J Gastrointest Oncol (2017)

AT-12 PHASE 1/2 STUDY OF TH-302, INVESTIGATIONAL HYPOXIA-ACTIVATED PRODRUG, AND BEVACIZUMAB IN PATIENTS WITH BEVACIZUMAB-REFRACTORY RECURRENT GLIOBLASTOMA

Por Brenner, Andrew, Floyd, John, Eng, Clarence, Kroll, Stew, Fichtel, Lisa, Gruslova, Aleksandra, Lodi, Alessia, Tiziani, Stefano
Publicado em 2014

DD-02 PHARMACODYNAMIC BIOMARKER ASSESSMENTS IN A PHASE I/II TRIAL OF THE HYPOXIA-ACTIVATED PRODRUG TH-302 AND BEVACIZUMAB IN BEVACIZUMAB-REFRACTORY RECURRENT GLIOBLASTOMA

Por Cavazos, David, Gruslova, Aleksandra, Sun, J., Floyd, John R., Fichtel, Lisa, Tadi, Surendar, Lodi, Alessia, Tiziani, Stefano, Hart, C.P., Eng, Clarence, Brenner, Andrew
Publicado no Neuro Oncol (2014)

VB-111: A novel anti-vascular therapeutic for glioblastoma multiforme

Por Gruslova, Aleksandra, Cavazos, David A, Miller, Jessica R., Breitbart, Eyal, Cohen, Yael C, Bangio, Livnat, Yakov, Niva, Soundararajan, Anu, Floyd, John R., Brenner, Andrew J.
Publicado no J Neurooncol (2015)

Hypothesizing that brain reward circuitry genes are genetic antecedents of pain sensitivity and critical diagnostic and pharmacogenomic treatment targets for chronic pain condition...

Por Chen, Amanda L.-C., Chen, Thomas J.H., Waite, Roger L., Reinking, Jeffrey, Tung, Howard L., Rhoades, Patrick, Downs, B. William, Braverman, Eric, Braverman, Dasha, Kerner, Mallory, Blum, Seth H., DiNubile, Nicholas, Smith, David, Oscar-Berman, Marlene, Prihoda, Thomas J., Floyd, John B., O’Brien, David, Liu, H.H., Blum, Kenneth
Publicado em 2008